Infectious Disease
circa early 20th century (retrospectively identified; earliest confirmed stored sample dated 1959, Leopoldville, Belgian Congo)
HIV, the virus responsible for AIDS, emerged into medical awareness in the early 1980s as one of the most significant infectious disease crises of the 20th century. Before the virus was identified, physicians struggled to explain a mysterious pattern of immune collapse appearing in clusters of patients, and the ensuing years of research produced some of the most rapid and consequential scientific discoveries in modern medical history. The social, political, and scientific dimensions of the epidemic's early history became inseparable from each other in ways that shaped medical institutions for decades.
Historical Narrative
Retrospective virological analysis conducted in later decades determined that HIV had been present in human populations long before it gained clinical recognition, with stored blood samples from the 1950s and 1960s in Central Africa testing positive for the virus. Phylogenetic studies eventually suggested that the virus had crossed from non-human primates to humans in the early 20th century, likely in the region of present-day Cameroon and the Democratic Republic of Congo, before spreading slowly and silently through human populations across subsequent decades.
The first official recognition of what would become known as AIDS came in June 1981, when the United States Centers for Disease Control published a brief report describing five cases of a rare lung infection, Pneumocystis carinii pneumonia, appearing in young men in Los Angeles. Within weeks, additional clusters of an unusual cancer called Kaposi's sarcoma were reported among young men in New York and California. Physicians of the time were deeply perplexed — both conditions had historically appeared almost exclusively in severely immunocompromised patients, yet the individuals now presenting with them had no obvious prior explanation for immune failure.
Dr. Michael Gottlieb at UCLA was among the earliest clinicians to document and report these cases systematically, and his careful record-keeping contributed to the initial CDC report. The early years of the epidemic saw intense debate among researchers about the cause of the immune collapse, with some theories focusing on lifestyle factors, repeated infections, or environmental exposures. The condition was initially labeled by the pejorative colloquial name GRID in some medical circles before the official term Acquired Immune Deficiency Syndrome — AIDS — was adopted in 1982.
The race to identify the causative agent became one of the most consequential and contested scientific investigations of the 20th century. In 1983, Françoise Barré-Sinoussi and Luc Montagnier at the Pasteur Institute in Paris isolated a novel retrovirus from a patient with swollen lymph nodes, which they called LAV. Nearly simultaneously, Robert Gallo's laboratory at the National Cancer Institute in the United States isolated a virus they called HTLV-III. The ensuing priority dispute over discovery between French and American teams became an internationally noted controversy, eventually resolved through diplomatic agreement between the governments of France and the United States. Barré-Sinoussi and Montagnier were awarded the Nobel Prize in Physiology or Medicine in 2008 for the discovery.
Once the virus was identified, the development of a blood test in 1985 transformed the epidemic's trajectory, enabling the screening of blood supplies and creating the infrastructure for epidemiological study on a global scale. Activists, particularly those affiliated with organizations like ACT UP founded in 1987, played a documented historical role in pressuring regulatory agencies to accelerate clinical trial processes and drug approvals, reshaping the relationship between patient advocacy and medical research institutions in ways that persisted long after the epidemic's acute crisis phase.
The mid-1990s brought a turning point when combination antiretroviral therapy, presented at the 1996 International AIDS Conference in Vancouver, dramatically altered survival outcomes in documented patient cohorts — a moment widely recorded in the history of medicine as one of the most sudden and dramatic therapeutic reversals in the modern era. The preceding fifteen years of research had transformed understanding of retroviruses, immunology, and epidemic response across the entire field of medicine.
Key Historical Figures
Historical narrative only — this page describes how HIV was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.